Title
Every Newborn: Health-systems bottlenecks and strategies to accelerate scale-up in countries
Date Issued
01 January 2014
Access level
metadata only access
Resource Type
review
Author(s)
Dickson K.E.
Simen-Kapeu A.
Kinney M.V.
Vesel L.
Lackritz E.
De Graft Johnson J.
Von Xylander S.
Rafique N.
Sylla M.
Mwansambo C.
Daelmans B.
Lawn J.E.
Publisher(s)
Elsevier B.V.
Abstract
Universal coverage of essential interventions would reduce neonatal deaths by an estimated 71%, benefit women and children after the first month, and reduce stillbirths. However, the packages with the greatest effect (care around birth, care of small and ill newborn babies), have low and inequitable coverage and are the most sensitive markers of health system function. In eight of the 13 countries with the most neonatal deaths (55% worldwide), we undertook a systematic assessment of bottlenecks to essential maternal and newborn health care, involving more than 600 experts. Of 2465 bottlenecks identified, common constraints were found in all high-burden countries, notably regarding the health workforce, financing, and service delivery. However, bottlenecks for specific interventions might differ across similar health systems. For example, the implementation of kangaroo mother care was noted as challenging in the four Asian country workshops, but was regarded as a feasible aspect of preterm care by respondents in the four African countries. If all high-burden countries achieved the neonatal mortality rates of their region's fastest progressing countries, then the mortality goal of ten or fewer per 1000 livebirths by 2035 recommended in this Series and the Every Newborn Action Plan would be exceeded. We therefore examined fast progressing countries to identify strategies to reduce neonatal mortality. We identified several key factors: (1) workforce planning to increase numbers and upgrade specific skills for care at birth and of small and ill newborn babies, task sharing, incentives for rural health workers; (2) financial protection measures, such as expansion of health insurance, conditional cash transfers, and performance-based financing; and (3) dynamic leadership including innovation and community empowerment. Adapting from the 2005 Lancet Series on neonatal survival and drawing on this Every Newborn Series, we propose a country-led, data-driven process to sharpen national health plans, seize opportunities to address the quality gap for care at birth and care of small and ill newborn babies, and systematically scale up care to reach every mother and newborn baby, particularly the poorest. © 2014 Elsevier Ltd.
Start page
438
End page
454
Volume
384
Issue
9941
Language
English
OCDE Knowledge area
Pediatría
Ciencias médicas, Ciencias de la salud
Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-84906069284
PubMed ID
Source
The Lancet
ISSN of the container
01406736
Sponsor(s)
This Series was undertaken in association with the Every Newborn Action Plan. Work for this paper was funded through a grant from USAID to UNICEF, and from the Bill & Melinda Gates Foundation to the US Fund for UNICEF. The Children's Investment Fund Foundation funded the epidemiological analysis through the London School of Hygiene and Tropical Medicine. This work would not have been possible without the country technical working groups and country workshop organisers and participants who did the bottleneck analyses. We thank Elsie Akwara and Christabel Nyange for data entry and literature searches and Shefali Oza, Hannah Blencowe, and Marek Lalli for epidemiological and coverage data analyses.
KED, AS-K, NR, and MS are employed by UNICEF. LV is a consultant to UNICEF supported by funding from a grant from the Bill & Melinda Gates Foundation. MVK is employed by Save the Children's SNL programme, which is funded by a grant from the Bill & Melinda Gates Foundation. EL is employed by the Global Alliance for Prevention of Prematurity and Stillbirths. LH received a grant from the Bill & Melinda Gates Foundation to do a case study that is captured in this paper. JdGJ is with MCHIP, which is funded through a grant from USAID. SvX and BD are employed by WHO. JEL is based at the London School of Hygiene and Tropical Medicine. Views expressed by the authors are their own and do not necessarily represent the views of their employing organisations.
Sources of information:
Directorio de Producción Científica
Scopus